The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Pancreas Devices Systems Market Outlook 2024
Synopsis
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
The global Artificial Pancreas Devices Systems market was valued at US$ 79 million in 2020 and is expected to reach US$ 176.6 million by the end of 2027, growing at a CAGR of 12.1% during 2021-2027.
This report focuses on Artificial Pancreas Devices Systems volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Artificial Pancreas Devices Systems market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Artificial Pancreas Devices Systems Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
The global Artificial Pancreas Devices Systems market was valued at US$ 79 million in 2020 and is expected to reach US$ 176.6 million by the end of 2027, growing at a CAGR of 12.1% during 2021-2027.
This report focuses on Artificial Pancreas Devices Systems volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Artificial Pancreas Devices Systems market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Artificial Pancreas Devices Systems Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Index1 Artificial Pancreas Devices Systems Market Overview
1.1 Product Overview and Scope of Artificial Pancreas Devices Systems
1.2 Artificial Pancreas Devices Systems Segment by Type
1.2.1 Global Artificial Pancreas Devices Systems Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Artificial Pancreas Devices Systems Segment by Application
1.3.1 Global Artificial Pancreas Devices Systems Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Artificial Pancreas Devices Systems Market Size Estimates and Forecasts
1.4.1 Global Artificial Pancreas Devices Systems Revenue 2016-2027
1.4.2 Global Artificial Pancreas Devices Systems Sales 2016-2027
1.4.3 Artificial Pancreas Devices Systems Market Size by Region: 2016 Versus 2021 Versus 2027
2 Artificial Pancreas Devices Systems Market Competition by Manufacturers
2.1 Global Artificial Pancreas Devices Systems Sales Market Share by Manufacturers (2016-2021)
2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Artificial Pancreas Devices Systems Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Artificial Pancreas Devices Systems Manufacturing Sites, Area Served, Product Type
2.5 Artificial Pancreas Devices Systems Market Competitive Situation and Trends
2.5.1 Artificial Pancreas Devices Systems Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artificial Pancreas Devices Systems Players Market Share by Revenue
2.5.3 Global Artificial Pancreas Devices Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Pancreas Devices Systems Retrospective Market Scenario by Region
3.1 Global Artificial Pancreas Devices Systems Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Artificial Pancreas Devices Systems Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.3.1 North America Artificial Pancreas Devices Systems Sales by Country
3.3.2 North America Artificial Pancreas Devices Systems Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.4.1 Europe Artificial Pancreas Devices Systems Sales by Country
3.4.2 Europe Artificial Pancreas Devices Systems Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Pancreas Devices Systems Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Pancreas Devices Systems Sales by Region
3.5.2 Asia Pacific Artificial Pancreas Devices Systems Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.6.1 Latin America Artificial Pancreas Devices Systems Sales by Country
3.6.2 Latin America Artificial Pancreas Devices Systems Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country
3.7.2 Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Artificial Pancreas Devices Systems Historic Market Analysis by Type
4.1 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2016-2021)
4.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2016-2021)
4.3 Global Artificial Pancreas Devices Systems Price by Type (2016-2021)
5 Global Artificial Pancreas Devices Systems Historic Market Analysis by Application
5.1 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2016-2021)
5.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2016-2021)
5.3 Global Artificial Pancreas Devices Systems Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Bigfoot Biomedical
6.2.1 Bigfoot Biomedical Corporation Information
6.2.2 Bigfoot Biomedical Description and Business Overview
6.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
6.2.5 Bigfoot Biomedical Recent Developments/Updates
6.3 Beta Bionics
6.3.1 Beta Bionics Corporation Information
6.3.2 Beta Bionics Description and Business Overview
6.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
6.3.5 Beta Bionics Recent Developments/Updates
6.4 Admetsys
6.4.1 Admetsys Corporation Information
6.4.2 Admetsys Description and Business Overview
6.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
6.4.5 Admetsys Recent Developments/Updates
6.5 Insulet
6.5.1 Insulet Corporation Information
6.5.2 Insulet Description and Business Overview
6.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
6.5.5 Insulet Recent Developments/Updates
6.6 Tandem Diabetes Care
6.6.1 Tandem Diabetes Care Corporation Information
6.6.2 Tandem Diabetes Care Description and Business Overview
6.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
6.6.5 Tandem Diabetes Care Recent Developments/Updates
6.7 Defymed
6.6.1 Defymed Corporation Information
6.6.2 Defymed Description and Business Overview
6.6.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
6.7.5 Defymed Recent Developments/Updates
7 Artificial Pancreas Devices Systems Manufacturing Cost Analysis
7.1 Artificial Pancreas Devices Systems Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Pancreas Devices Systems
7.4 Artificial Pancreas Devices Systems Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Pancreas Devices Systems Distributors List
8.3 Artificial Pancreas Devices Systems Customers
9 Artificial Pancreas Devices Systems Market Dynamics
9.1 Artificial Pancreas Devices Systems Industry Trends
9.2 Artificial Pancreas Devices Systems Growth Drivers
9.3 Artificial Pancreas Devices Systems Market Challenges
9.4 Artificial Pancreas Devices Systems Market Restraints
10 Global Market Forecast
10.1 Artificial Pancreas Devices Systems Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Pancreas Devices Systems by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Artificial Pancreas Devices Systems by Type (2022-2027)
10.2 Artificial Pancreas Devices Systems Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Pancreas Devices Systems by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Artificial Pancreas Devices Systems by Application (2022-2027)
10.3 Artificial Pancreas Devices Systems Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Pancreas Devices Systems by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Artificial Pancreas Devices Systems by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Artificial Pancreas Devices Systems Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Artificial Pancreas Devices Systems Sales (Units) Comparison by Application (2021-2027)
Table 3. Global Artificial Pancreas Devices Systems Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Artificial Pancreas Devices Systems Covered in This Study
Table 5. Global Artificial Pancreas Devices Systems Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global Artificial Pancreas Devices Systems Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Artificial Pancreas Devices Systems Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Artificial Pancreas Devices Systems Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Artificial Pancreas Devices Systems Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Artificial Pancreas Devices Systems Manufacturing Sites and Area Served
Table 11. Manufacturers Artificial Pancreas Devices Systems Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Artificial Pancreas Devices Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Pancreas Devices Systems as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Artificial Pancreas Devices Systems Sales by Region (2016-2021) & (Units)
Table 16. Global Artificial Pancreas Devices Systems Sales Market Share by Region (2016-2021)
Table 17. Global Artificial Pancreas Devices Systems Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Artificial Pancreas Devices Systems Sales by Country (2016-2021) & (Units)
Table 19. North America Artificial Pancreas Devices Systems Sales Market Share by Country (2016-2021)
Table 20. North America Artificial Pancreas Devices Systems Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Artificial Pancreas Devices Systems Revenue Market Share by Country (2016-2021)
Table 22. Europe Artificial Pancreas Devices Systems Sales by Country (2016-2021) & (Units)
Table 23. Europe Artificial Pancreas Devices Systems Sales Market Share by Country (2016-2021)
Table 24. Europe Artificial Pancreas Devices Systems Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Artificial Pancreas Devices Systems Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Artificial Pancreas Devices Systems Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific Artificial Pancreas Devices Systems Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Artificial Pancreas Devices Systems Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Artificial Pancreas Devices Systems Revenue Market Share by Region (2016-2021)
Table 30. Latin America Artificial Pancreas Devices Systems Sales by Country (2016-2021) & (Units)
Table 31. Latin America Artificial Pancreas Devices Systems Sales Market Share by Country (2016-2021)
Table 32. Latin America Artificial Pancreas Devices Systems Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Artificial Pancreas Devices Systems Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa Artificial Pancreas Devices Systems Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Artificial Pancreas Devices Systems Revenue Market Share by Country (2016-2021)
Table 38. Global Artificial Pancreas Devices Systems Sales (Units) by Type (2016-2021)
Table 39. Global Artificial Pancreas Devices Systems Sales Market Share by Type (2016-2021)
Table 40. Global Artificial Pancreas Devices Systems Revenue (Million US$) by Type (2016-2021)
Table 41. Global Artificial Pancreas Devices Systems Revenue Share by Type (2016-2021)
Table 42. Global Artificial Pancreas Devices Systems Price (USD/Unit) by Type (2016-2021)
Table 43. Global Artificial Pancreas Devices Systems Sales (Units) by Application (2016-2021)
Table 44. Global Artificial Pancreas Devices Systems Sales Market Share by Application (2016-2021)
Table 45. Global Artificial Pancreas Devices Systems Revenue (Million US$) by Application (2016-2021)
Table 46. Global Artificial Pancreas Devices Systems Revenue Share by Application (2016-2021)
Table 47. Global Artificial Pancreas Devices Systems Price (USD/Unit) by Application (2016-2021)
Table 48. Medtronic Corporation Information
Table 49. Medtronic Description and Business Overview
Table 50. Medtronic Artificial Pancreas Devices Systems Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Medtronic Artificial Pancreas Devices Systems Product
Table 52. Medtronic Recent Developments/Updates
Table 53. Bigfoot Biomedical Corporation Information
Table 54. Bigfoot Biomedical Description and Business Overview
Table 55. Bigfoot Biomedical Artificial Pancreas Devices Systems Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Bigfoot Biomedical Artificial Pancreas Devices Systems Product
Table 57. Bigfoot Biomedical Recent Developments/Updates
Table 58. Beta Bionics Corporation Information
Table 59. Beta Bionics Description and Business Overview
Table 60. Beta Bionics Artificial Pancreas Devices Systems Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Beta Bionics Artificial Pancreas Devices Systems Product
Table 62. Beta Bionics Recent Developments/Updates
Table 63. Admetsys Corporation Information
Table 64. Admetsys Description and Business Overview
Table 65. Admetsys Artificial Pancreas Devices Systems Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Admetsys Artificial Pancreas Devices Systems Product
Table 67. Admetsys Recent Developments/Updates
Table 68. Insulet Corporation Information
Table 69. Insulet Description and Business Overview
Table 70. Insulet Artificial Pancreas Devices Systems Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Insulet Artificial Pancreas Devices Systems Product
Table 72. Insulet Recent Developments/Updates
Table 73. Tandem Diabetes Care Corporation Information
Table 74. Tandem Diabetes Care Description and Business Overview
Table 75. Tandem Diabetes Care Artificial Pancreas Devices Systems Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Tandem Diabetes Care Artificial Pancreas Devices Systems Product
Table 77. Tandem Diabetes Care Recent Developments/Updates
Table 78. Defymed Corporation Information
Table 79. Defymed Description and Business Overview
Table 80. Defymed Artificial Pancreas Devices Systems Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Defymed Artificial Pancreas Devices Systems Product
Table 82. Defymed Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Artificial Pancreas Devices Systems Distributors List
Table 86. Artificial Pancreas Devices Systems Customers List
Table 87. Artificial Pancreas Devices Systems Market Trends
Table 88. Artificial Pancreas Devices Systems Growth Drivers
Table 89. Artificial Pancreas Devices Systems Market Challenges
Table 90. Artificial Pancreas Devices Systems Market Restraints
Table 91. Global Artificial Pancreas Devices Systems Sales Forecast by Type (2022-2027) & (Units)
Table 92. Global Artificial Pancreas Devices Systems Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Artificial Pancreas Devices Systems Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Artificial Pancreas Devices Systems Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Artificial Pancreas Devices Systems Sales Forecast by Application (2022-2027) & (Units)
Table 96. Global Artificial Pancreas Devices Systems Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Artificial Pancreas Devices Systems Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Artificial Pancreas Devices Systems Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Artificial Pancreas Devices Systems Sales Forecast by Region (2022-2027) & (Units)
Table 100. Global Artificial Pancreas Devices Systems Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Artificial Pancreas Devices Systems Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Artificial Pancreas Devices Systems Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artificial Pancreas Devices Systems
Figure 2. Global Artificial Pancreas Devices Systems Market Share by Type in 2020 & 2027
Figure 3. Threshold Suspended Device Systems Product Picture
Figure 4. Hybrid Closed-loop APDS Product Picture
Figure 5. Other Systems Product Picture
Figure 6. Global Artificial Pancreas Devices Systems Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Global Artificial Pancreas Devices Systems Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Artificial Pancreas Devices Systems Market Size 2016-2027 (US$ Million)
Figure 11. Global Artificial Pancreas Devices Systems Sales 2016-2027 (Units)
Figure 12. Global Artificial Pancreas Devices Systems Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Artificial Pancreas Devices Systems Sales Share by Manufacturers in 2020
Figure 14. Global Artificial Pancreas Devices Systems Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Artificial Pancreas Devices Systems Players: Market Share by Revenue in 2020
Figure 16. Artificial Pancreas Devices Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Artificial Pancreas Devices Systems Sales Market Share by Region (2016-2021)
Figure 18. Global Artificial Pancreas Devices Systems Sales Market Share by Region in 2020
Figure 19. Global Artificial Pancreas Devices Systems Revenue Market Share by Region (2016-2021)
Figure 20. Global Artificial Pancreas Devices Systems Revenue Market Share by Region in 2020
Figure 21. U.S. Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Artificial Pancreas Devices Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Artificial Pancreas Devices Systems by Type (2016-2021)
Figure 46. Sales Market Share of Artificial Pancreas Devices Systems by Application (2016-2021)
Figure 47. Sales Market Share of Artificial Pancreas Devices Systems by Application in 2020
Figure 48. Revenue Share of Artificial Pancreas Devices Systems by Application (2016-2021)
Figure 49. Revenue Share of Artificial Pancreas Devices Systems by Application in 2020
Figure 50. Manufacturing Cost Structure of Artificial Pancreas Devices Systems
Figure 51. Manufacturing Process Analysis of Artificial Pancreas Devices Systems
Figure 52. Artificial Pancreas Devices Systems Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
